A rising tide is lifting all ships in cannabis right now.
The legalization of cannabis in several key states has increased industry excitement about the potential of the U.S. market, prompting shares of many cannabis stocks to rally hard.
But the good news is not limited to just the U.S. Elsewhere, cannabis activity in major overseas markets are continuing to rise.
Latin America (Latam)-based Khiron Life Sciences (OTCQX: KHRNF), a cannabis operator focused on the medical and health & wellness markets, recently reported more than 4,600 prescriptions filled in Latin America, including 1,300 for the month of October, a 130% increase from July.
In all, the company reported that total monthly patient consultations at Khiron clinics increased to over …